Drugs / Human Dental Fulp Stem Cells
Human Dental Fulp Stem Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05924373 | Nov 2023 → Mar 2025 overdue | chronic periodontitis | Peking University Third Hospital | Recruiting | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Dental Fulp Stem Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05924373 ↗ |
| Known as | DPSC | “In this study, a human dental pulp stem cell (DPSC; hDP-MSC) injection was developed to promote periodontal regeneration through a non-invasive procedure.” PMID 40739139 ↗ Jul 2025 |
| Known as | DPSCs | “Thirty-six were randomly assigned to different DPSC dose groups (ranging from 1 × 106 to 1 × 107 DPSCs per tooth” PMID 40739139 ↗ Jul 2025 |
| Known as | hDP-MSC | “In this study, a human dental pulp stem cell (DPSC; hDP-MSC) injection was developed to promote periodontal regeneration through a non-invasive procedure.” PMID 40739139 ↗ Jul 2025 |
| Modality | Cell therapy | “a human dental pulp stem cell (DPSC; hDP-MSC) injection” PMID 40739139 ↗ Jul 2025 |
| Route | Other | “human pulp stem cell injections will be given for a single or two local injection” NCT05924373 ↗ |